PTEN used to be believed as a classic tumor suppressor, low expression of PTEN protein due to gene mutation or missing may excessively activate PIK3CA/AKT signal pathway and drive the process of development and metastasis of tumor [38], which related to poor prognosis of nonsmall cell lung cancer and TKIs resistance [39, 40]. This evidence concerns the gene AKT1 and lung cancer.